Cargando…
The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines
In this article, we trace the chronology of developments in breast imaging technologies that are used for diagnosis and staging of breast cancer, including mammography, ultrasonography, magnetic resonance imaging, computed tomography, and positron emission tomography. We explore factors that affecte...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266577/ https://www.ncbi.nlm.nih.gov/pubmed/22275726 http://dx.doi.org/10.1102/1470-7330.2012.0003 |
_version_ | 1782222192127246336 |
---|---|
author | Gold, Laura S. Klein, Gregory Carr, Lauren Kessler, Larry Sullivan, Sean D. |
author_facet | Gold, Laura S. Klein, Gregory Carr, Lauren Kessler, Larry Sullivan, Sean D. |
author_sort | Gold, Laura S. |
collection | PubMed |
description | In this article, we trace the chronology of developments in breast imaging technologies that are used for diagnosis and staging of breast cancer, including mammography, ultrasonography, magnetic resonance imaging, computed tomography, and positron emission tomography. We explore factors that affected clinical acceptance and utilization of these technologies from discovery to clinical use, including milestones in peer-reviewed publication, US Food and Drug Administration approval, reimbursement by payers, and adoption into clinical guidelines. The factors driving utilization of new imaging technologies are mainly driven by regulatory approval and reimbursement by payers rather than evidence that they provide benefits to patients. Comparative effectiveness research can serve as a useful tool to investigate whether these imaging modalities provide information that improves patient outcomes in real-world settings. |
format | Online Article Text |
id | pubmed-3266577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | e-Med |
record_format | MEDLINE/PubMed |
spelling | pubmed-32665772014-01-25 The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines Gold, Laura S. Klein, Gregory Carr, Lauren Kessler, Larry Sullivan, Sean D. Cancer Imaging Original Article In this article, we trace the chronology of developments in breast imaging technologies that are used for diagnosis and staging of breast cancer, including mammography, ultrasonography, magnetic resonance imaging, computed tomography, and positron emission tomography. We explore factors that affected clinical acceptance and utilization of these technologies from discovery to clinical use, including milestones in peer-reviewed publication, US Food and Drug Administration approval, reimbursement by payers, and adoption into clinical guidelines. The factors driving utilization of new imaging technologies are mainly driven by regulatory approval and reimbursement by payers rather than evidence that they provide benefits to patients. Comparative effectiveness research can serve as a useful tool to investigate whether these imaging modalities provide information that improves patient outcomes in real-world settings. e-Med 2012-01-25 /pmc/articles/PMC3266577/ /pubmed/22275726 http://dx.doi.org/10.1102/1470-7330.2012.0003 Text en © 2012 International Cancer Imaging Society |
spellingShingle | Original Article Gold, Laura S. Klein, Gregory Carr, Lauren Kessler, Larry Sullivan, Sean D. The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines |
title | The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines |
title_full | The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines |
title_fullStr | The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines |
title_full_unstemmed | The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines |
title_short | The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines |
title_sort | emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266577/ https://www.ncbi.nlm.nih.gov/pubmed/22275726 http://dx.doi.org/10.1102/1470-7330.2012.0003 |
work_keys_str_mv | AT goldlauras theemergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT kleingregory theemergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT carrlauren theemergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT kesslerlarry theemergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT sullivanseand theemergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT goldlauras emergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT kleingregory emergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT carrlauren emergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT kesslerlarry emergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines AT sullivanseand emergenceofdiagnosticimagingtechnologiesinbreastcancerdiscoveryregulatoryapprovalreimbursementandadoptioninclinicalguidelines |